YS Biopharma is a global biopharmaceutical company specializing in the discovery, development, manufacturing, and commercialization of vaccines and therapeutic biologics for infectious diseases and cancer. With a focus on innovative immunotherapeutics, the company is dedicated to advancing novel PIKA-based vaccines for infectious diseases such as COVID-19, hepatitis B, rabies, and flu, as well as developing PIKA-based immuno-oncology therapeutics for the treatment of advanced solid tumors.
Utilizing their proprietary PIKA immunomodulating technology platform, YS Biopharma aims to develop a diverse range of biotherapeutics by activating multiple pathways of immune signaling. This technology holds promise for the development of antiviral vaccines, antiviral therapeutics, and anticancer therapeutics, making YS Biopharma a key player in the global vaccine and pharmaceutical industry.
Generated from the website